Publicação em atas de evento científico
Evaluating the bioequivalence of treatments using t-ratios tests
Maria Filomena Teodoro (Teodoro, M. F.); Andrade, M. A. (Andrade, M. A. P.); Teresa A. Oliveira (Oliveira, T. A.);
ICoMS '24: Proceedings of the 2024 7th International Conference on Mathematics and Statistics
Ano (publicação definitiva)
2024
Língua
Inglês
País
Estados Unidos da América
Mais Informação
Web of Science®

Esta publicação não está indexada na Web of Science®

Scopus

N.º de citações: 0

(Última verificação: 2026-06-25 01:40)

Ver o registo na Scopus

Google Scholar

N.º de citações: 0

(Última verificação: 2026-06-28 17:57)

Ver o registo no Google Scholar

Esta publicação não está indexada no Overton

Abstract/Resumo
The main objective of the work is the application of experimental design and some simple tests (t-ratios) in the evaluation of bioequivalence of two treatments. It is performed the assessment of the effectiveness of different treatments administered to two groups of patients: the control group and the test group. The comparison of the control group that received the reference medication with the control group test, which received the drug under study, using a crossover experimental design. It was performed an analysis using t-ratios and considering and inter-subject variability formulation of the probabilistic model, where the specification of tests for detection of carryover and period effects were considered. The application to a practical case consisted in the validation of the hypothesis of the proposed model took place, where the effects carryover and period were not significant when considering usual levels of significance. About the treatments, we could conclude that there was statistical significance to affirm that the studied pharmaceuticals were not bioequivalent.
Agradecimentos/Acknowledgements
The second author was partially supported by Fundação para a Ciência e Tecnologia, I.P. (FCT) [ISTAR Projects: UIDB/04466/2020 and UIDP/04466/2020].
Palavras-chave
Experimental design,Clinical trials,Bioequivalence
Registos de financiamentos
Referência de financiamento Entidade Financiadora
UIDB/Multi/04621/2020 Fundação para a Ciência e a Tecnologia
UIDB/04466/2020 Fundação para a Ciência e a Tecnologia